Genetic Risk Score Constructed Using 14 Susceptibility Alleles for Type 2 Diabetes Is Associated With the Early Onset of Diabetes and May Predict the Future Requirement of Insulin Injections Among Japanese Individuals

Autor: Hiromi Kato, Minoru Iwata, Atsuko Takano, Shiro Maeda, Kazuo Hara, Takashi Kadowaki, Shihou Murakami, Atsushi Takahashi, Yutaka Kamura, Kiyohiro Higuchi, Kazuyuki Tobe, Hayato Fujita
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Oncology
Male
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Type 2 diabetes
0302 clinical medicine
Insulin
Age of Onset
Cation Transport Proteins
Original Research
0303 health sciences
tRNA Methyltransferases
SLC30A8
biology
Middle Aged
3. Good health
KCNQ1 Potassium Channel
Female
Transcription Factor 7-Like 2 Protein
medicine.medical_specialty
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
030209 endocrinology & metabolism
Single-nucleotide polymorphism
Zinc Transporter 8
Polymorphism
Single Nucleotide

03 medical and health sciences
Asian People
Diabetes mellitus
Internal medicine
Internal Medicine
medicine
Humans
Genetic Predisposition to Disease
Potassium Channels
Inwardly Rectifying

Pathophysiology/Complications
CDKAL1
Alleles
030304 developmental biology
Adaptor Proteins
Signal Transducing

Aged
Cyclin-Dependent Kinase Inhibitor p15
Advanced and Specialized Nursing
Homeodomain Proteins
business.industry
fungi
Proteins
Cyclin-Dependent Kinase 5
medicine.disease
PPAR gamma
Endocrinology
Diabetes Mellitus
Type 2

Ubiquitin-Conjugating Enzymes
biology.protein
Insulin Receptor Substrate Proteins
Age of onset
business
TCF7L2
Transcription Factors
Zdroj: Diabetes Care
ISSN: 1935-5548
0149-5992
Popis: OBJECTIVE We evaluated the clinical usefulness of a genetic risk score (GRS) based on 14 well-established variants for type 2 diabetes. RESEARCH DESIGN AND METHODS We analyzed 14 SNPs at HHEX, CDKAL1, CDKN2B, SLC30A8, KCNJ11, IGF2BP2, PPARG, TCF7L2, FTO, KCNQ1, IRS-1, GCKR, UBE2E2, and C2CD4A/B in 1,487 Japanese individuals (724 patients with type 2 diabetes and 763 control subjects). A GRS was calculated according to the number of risk alleles by counting all 14 SNPs (T-GRS) as well as 11 SNPs related to β-cell function (β-GRS) and then assessing the association between each GRS and the clinical features. RESULTS Among the 14 SNPs, 4 SNPs were significantly associated with type 2 diabetes in the present Japanese sample (P < 0.0036). The T-GRS was significantly associated with type 2 diabetes (P = 5.9 × 10−21). Among the subjects with type 2 diabetes, the β-GRS was associated with individuals receiving insulin therapy (β = 0.0131, SE = 0.006, P = 0.0431), age at diagnosis (β = −0.608, SE = 0.204, P = 0.0029), fasting serum C-peptide level (β = −0.032, SE = 0.0140, P = 0.022), and C-peptide index (β = −0.031, SE = 0.012, P = 0.0125). CONCLUSIONS Our data suggest that the β-GRS is associated with reduced β-cell functions and may be useful for selecting patients who should receive more aggressive β-cell–preserving therapy.
Databáze: OpenAIRE